From February 6, 2024 to March 31, 2024, the company has repurchased 99,900 shares, representing 0.02% for CNY 2.94 million. With this, the company has completed the repurchase of 99,900 shares, representing 0.02% for CNY 2.94 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.83 CNY | +1.02% | -3.78% | -0.49% |
05-07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
05-07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.49% | 2.02B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.